General medical conditions are associated with delay to treatment in patients with bipolar disorder

Psychosomatics

Volumn 54, Issue 5, 2013, Pages 437-442

  Maina, Giuseppe ^a   Bechon, Elisa ^a   Rigardetto, Sylvia ^a   Salvi, Virginio ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Bipolar disorder; Cardiovascular disease; Duration of untreated illness; General medical conditions

Indexed keywords

ADULT; ARTICLE; BIPOLAR DISORDER; CARDIOVASCULAR DISEASE; COMORBIDITY; DEMOGRAPHY; ENDOCRINE DISEASE; FEMALE; HUMAN; HYPERTENSION; ICD-10; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; PREVALENCE; RATING SCALE; VASCULAR DISEASE;

BIPOLAR DISORDER; CARDIOVASCULAR DISEASE; DURATION OF UNTREATED ILLNESS; GENERAL MEDICAL CONDITIONS;

ADULT; AGE OF ONSET; AGED; BIPOLAR DISORDER; CARDIOVASCULAR DISEASES; DELAYED DIAGNOSIS; DIABETES MELLITUS; DIGESTIVE SYSTEM DISEASES; FEMALE; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TIME-TO-TREATMENT;

EID: 84883766691     PISSN: 00333182     EISSN: 15457206     Source Type: Journal    
DOI: 10.1016/j.psym.2012.10.011     Document Type: Article

References (32)

1. Osby U., Brandt L., Correia N., Ekbom A., Sparén P. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry 2001, 58(9):844-850.
2. Colton C.W., Manderscheid R.W. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev Chronic Dis 2006, 3(2):A42.
3. Osborn D.P.J., Levy G., Nazareth I., Petersen I., Islam A., King M.B. Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's general practice research database. Arch Gen Psychiatry 2007, 64(2):242-249.
4. Magalhães P.V., Kapczinski F., Nierenberg A.A., Deckersbach T., Weisinger D., Dodd S., et al. Illness burden and medical comorbidity in the systematic treatment Enhancement Program for Bipolar Disorder. Acta Psychiatr Scand 2012, 125(4):303-308.
5. Carney C.P., Jones L.E. Medical comorbidity in women and men with bipolar disorders: a population-based controlled study. Psychosom Med 2006, 68(5):684-691.
6. Perron B.E., Howard M.O., Nienhuis J.K., Bauer M.S., Woodward A.T., Kilbourne A.M. Prevalence and burden of general medical conditions among adults with bipolar I disorder: results from the national Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2009, 70(10):1407-1415.
7. Weber N.S., Fisher J.A., Cowan D.N., Niebuhr D.W. Psychiatric and general medical conditions comorbid with bipolar disorder in the national hospital Discharge Survey. Psychiatr Serv 2011, 62(10):1152-1158.
8. Laursen T.M., Munk-Olsen T., Gasse C. Chronic somatic comorbidity and excess mortality due to natural causes in persons with schizophrenia or bipolar affective disorder. PLoS ONE 2001, 6(9):e24597.
9. Ruzickova M., Slaney C., Garnham J., Alda M. Clinical features of bipolar disorder with and without comorbid diabetes mellitus. Can J Psychiatry 2003, 48(7):458-461.
10. Fagiolini A., Kupfer D.J., Houck P.R., Novick D.M., Frank E. Obesity as a correlate of outcome in patients with bipolar I disorder. Am J Psychiatry 2003, 160(1):112-117.
11. Fagiolini A., Kupfer D.J., Rucci P., Scott J.A., Novick D.M., Frank E. Suicide attempts and ideation in patients with bipolar I disorder. J Clin Psychiatry 2004, 65(4):509-514.
12. Kemp D.E., Gao K., Ganocy S.J., Caldes E., Feldman K., Chan P.K., et al. Medical and substance use comorbidity in bipolar disorder. J Affect Disord 2009, 116(1-2):64-69.
13. Goldberg J.F., Ernst C.L. Features associated with the delayed initiation of mood stabilizers at illness onset in bipolar disorder. J Clin Psychiatry 2002, 63(11):985-991.
14. Perlis R.H., Miyahara S., Marangell L.B., Wisniewski S.R., Ostacher M., DelBello M.P., et al. Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment Enhancement Program for Bipolar Disorder (STEP-BD). Biol Psychiatry 2004, 55(9):875-881.
15. Hamshere M.L., Gordon-Smith K., Forty L., Jones L., Caesar S., Fraser C., et al. Age-at-onset in bipolar-I disorder: mixture analysis of 1369 cases identifies three distinct clinical sub-groups. J Affect Disord 2009, 116(1-2):23-29.
16. Altamura A.C., Dell'Osso B., Berlin H.A., Buoli M., Bassetti R., Mundo E. Duration of untreated illness and suicide in bipolar disorder: a naturalistic study. Eur Arch Psychiatry Clin Neurosci 2010, 260(5):385-391.
17. Bauer M., Glenn T., Rasgon N., Marsh W., Sagduyu K., Munoz R., et al. Association between age of onset and mood in bipolar disorder: comparison of subgroups identified by cluster analysis and clinical observation. J Psychiatr Res 2010, 44(16):1170-1175.
18. Tondo L., Lepri B., Cruz N., Baldessarini R.J. Age at onset in 3014 Sardinian bipolar and major depressive disorder patients. Acta Psychiatr Scand 2010, 121(6):446-452.
19. Drancourt N., Etain B., Lajnef M., Henry C., Raust A., Cochet B., et al. Duration of untreated bipolar disorder: missed opportunities on the long road to optimal treatment. Acta Psychiatr Scand 2012 Aug 20, [Epub ahead of print].
20. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for the Diagnostic and Statistical Manual 1997, American Psychiatric Publishing, Washington, DC, Patient Version. 4th ed.
21. Linn B.S., Linn M.W., Gurel L. Cumulative illness rating scale. J Am Geriatr Soc 1968, 16(5):622-626.
22. Hudon C., Fortin M., Vanasse A. Cumulative Illness Rating Scale was a reliable and valid index in a family practice context. J Clin Epidemiol 2005, 58(6):603-608.
23. Soreca I., Fagiolini A., Frank E., Houck P.R., Thompson W.K., Kupfer D.J. Relationship of general medical burden, duration of illness and age in patients with bipolar I disorder. J Psychiatr Res 2008, 42(11):956-961.
24. Kilbourne A.M., Cornelius J.R., Han X., Pincus H.A., Shad M., Salloum I., et al. Burden of general medical conditions among individuals with bipolar disorder. Bipolar Disord 2004, 6(5):368-373.
25. Correll C.U., Frederickson A.M., Kane J.M., Manu P. Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugs. J Clin Psychiatry 2006, 67(4):575-583.
26. Salvi V., D'Ambrosio V., Bogetto F., Maina G. Metabolic syndrome in Italian patients with bipolar disorder: a 2-year follow-up study. J Affect Disord 2012, 136(3):599-603.
27. Matthews A.M., Huckans M.S., Blackwell A.D., Hauser P. Hepatitis C testing and infection rates in bipolar patients with and without comorbid substance use disorders. Bipolar Disord 2008, 10(2):266-270.
28. Fuller B.E., Rodriguez V.L., Linke A., Sikirica M., Dirani R., Hauser P. Prevalence of liver disease in veterans with bipolar disorder or schizophrenia. Gen Hosp Psychiatry 2011, 33(3):232-237.
29. Morris C.D., Giese A.A., Turnbull J.J., Dickinson M., Johnson-Nagel N. Predictors of tobacco use among persons with mental illnesses in a statewide population. Psychiatr Serv 2006, 57(7):1035-1038.
30. Miller B.J., Paschall C.B., Svendsen D.P. Mortality and medical comorbidity among patients with serious mental illness. Psychiatr Serv 2006, 57(10):1482-1487.
31. Rizos E.N., Michalopoulou P.G., Siafakas N., Stefanis N., Douzenis A., Rontos I., et al. Association of serum brain-derived neurotrophic factor and duration of untreated psychosis in first-episode patients with schizophrenia. Neuropsychobiology 2010, 62(2):87-90.
32. Krabbe K.S., Nielsen A.R., Krogh-Madsen R., Plomgaard P., Rasmussen P., Erikstrup C., et al. Brain-derived neurotrophic factor (BDNF) and type 2 diabetes. Diabetologia 2007, 50(2):431-438.